MTC Awards $1.4 Million in the April 2024 Investment Cycle

During the April 2024 Board of Directors meeting, $1.4 million was approved for equity-based investments through MTC’s state-sponsored venture capital program (IDEA Fund) in the following companies:

  • DevStride, Corp. is an integrated project and portfolio management solution designed for complex organizations that want to bridge the gap between internal agile practices and rigid external commitments. DevStride eases friction between agile workflows and regulatory, statutory and contractual requirements by meeting stakeholders where they are in their agile transformation journeys.
  • Facility Ally, LLC helps manage court/field bookings, leagues (sign ups, waivers, schedules, scores, standings, and more), event sign-ups, lessons, classes, memberships, and more all in one system.
  • Maximum Fidelity Surgical Simulations, LLC creates hyper-realistic surgical simulations using EnvivoPC, which is a patented and proprietary cadaver perfusion system. Customizing every surgical simulation experience to match the unique needs of their customers, whether it is for military training, research and product development, or medical education.
  • Pairidex, Inc. is a clinical diagnostics company that offers laboratory-based testing for cancer detection. Pairidex uses patent-pending technology to accurately detect gene fusion-driven cancer at lower levels than any other tests, allowing for earlier detection of disease or relapse. Initially we are focused on blood cancers—specifically leukemia.
  • Trelus, Inc. is a subscription-based, SaaS platform and digital roadmap giving founders and owners step-by-step guidance, AI-powered workflow and resources to maximize value and ensure exit readiness long before they exit.

Since January 2023, MTC has awarded over $11M in investment allocations through the IDEA Fund to nearly 40 Missouri-based high-growth potential startups.

MTC accepts IDEA Fund applications continuously and reviews applications on a quarterly cycle to determine award allocation. Awarded companies have up to one year to secure the matching co-investment, close their funding round, and receive MTC’s investment.

The deadlines for full consideration for each quarterly application review cycle are listed below.

  • July 2024 Award Cycle – Application deadline of 11:59pm, Wednesday, May 8, 2024
  • October 2024 Award Cycle – Application deadline of 11:59pm, Wednesday, August 7, 2024